Objectives: To comprehensively classify interventions performed by pediatric critical care clinical pharmacists and quantify cost avoidance (CA) generated through their accepted interventions.
Design: A multicenter, prospective, observational study performed between August 2018 and January 2019.
Setting: Academic and community hospitals in the United States with pediatric critical care units.